According to some recent studies, the 2021-22 flu season is expected to be strong, and there's an increasing overlap in symptoms between the predominant SARS-CoV-2 variants and Influenza or Respiratory Syncytial Virus (RSV). Therefore, the research challenge will be to discriminate between the different co-circulating viruses reliably.

Detection of several targets in one PCR reaction may require a time-consuming optimization process or even special equipment. Sub-optimal reaction parameters like primer and probe concentrations, master mix composition, fluorophores, cycling conditions, etc., may generate sub-optimal results.

This session will introduce a primer and probe kit that integrates seamlessly with our universal, fast-track QIAprep&amp workflow and accurately differentiates the viruses without requiring a separate extraction step or investment in special equipment or software. 

You will learn: 

• How to expand your SARS-CoV-2 research to other respiratory viruses
• How to streamline and accelerate your workflow
• How to optimize your overall research costs